1. Andrew Z,Fire 美国 Stanford University 2006美国医学院院士;2004美国科学院院士;2006诺贝尔生理学或医学奖 A novel TRIP11-FLT3 fusion in a patient with a myeloid/lymphoid neoplasm with eosinophilia
2. Huber, Robert 德国 Max-Planck-Institut für Biochemie 1995美国科学院院士;1988诺贝尔化学奖 Syringolin A Selectively Labels the 20 S Proteasome in Murine EL4 and Wild-Type and Bortezomib-Adapt..
3. Evans, William E. 美国 St. Jude Children's Research Hospital 2002美国医学院院士 Genome-wide CRISPR screen reveals PSMA6 to be an essential gene in pancreatic cancer cells
4. Fischbeck, Kenneth H. 美国 National Institutes of Health 1999美国医学院院士 CNS uptake of bortezomib is enhanced by P-glycoprotein inhibition: implications for spinal muscular ..
5. Anderson, Kenneth C. 美国 Harvard Medical School 2010美国医学院院士 Resistance to Proteasome Inhibitors in Multiple Myeloma
6. Anderson, Kenneth C. 美国 Harvard Medical School 2010美国医学院院士 Sequence analysis of beta-subunit genes of the 20S proteasome in patients with relapsed multiple mye..
7. 丁健 中国 中国科学院 中国工程院院士 Characterization of dihydroartemisinin-resistant colon carcinoma HCT116/R cell line
8. Schiffer, Celia A. 美国 University of Massachusetts Chan Medical School 2024美国科学院院士 The challenge of developing robust drugs to overcome resistance
9. Lewis E. Kay 加拿大 University of Toronto 2020美国科学院院士 Novel Proteasome Inhibitors to Overcome Bortezomib Resistance
10. Campo, Elias 西班牙 University of Barcelona 2018美国医学院院士 The Hsp90 inhibitor IPI-504 overcomes bortezomib resistance in mantle cell lymphoma in vitro and in ..
11. Louis M. Staudt 美国 National Institutes of Health 2013美国科学院院士;2020美国医学院院士 Bortezomib resistance in mantle cell lymphoma is associated with plasmacytic differentiation
12. 朱维良 中国 中国科学院 Dihydrocelastrol induces antitumor activity and enhances the sensitivity of bortezomib in resistant ..
13. Richardson, Des R. 澳大利亚 Griffith University The Myc Family and the Metastasis Suppressor NDRG1 Targeting Key Molecular Interactions with Innovat..
14. Recher, Christian 法国 Institute University Cancer Toulouse Oncopole LSC17 score complements genetics and measurable residual disease in acute myeloid leukemia: an ALFA ..
15. Herve,Dombret 法国 Hopital of St Louis LSC17 score complements genetics and measurable residual disease in acute myeloid leukemia: an ALFA ..
16. Claude,Preudhomme 法国 Universite de Lille 2 LSC17 score complements genetics and measurable residual disease in acute myeloid leukemia: an ALFA ..
17. Mauro,Krampera 意大利 University of Verona Immunophenotypic measurable residual disease monitoring in adult acute lymphoblastic leukemia patien..
18. Nicot, Christophe 美国 University of Kansas Targeting Pim kinases in hematological cancers: molecular and clinical review
19. 唐道林 中国 广州医科大学 Pharmacological characterization of a novel metal-based proteasome inhibitor Na-AuPT for cancer trea..
20. 窦庆平 美国 Wayne State University 博士 教授 Pharmacological characterization of a novel metal-based proteasome inhibitor Na-AuPT for cancer trea..